• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

A BRCA1 Splice Site Variant Responsible for Familial Ovarian Cancer in a Han-Chinese Family

摘要Ovarian cancer(OC)is one of the most common and most lethal gynecological malignancies.OC has an age-dependent incidence and occurs more commonly in females older than 50 years old.Most OC patients are diagnosed at an advanced stage and have a poor prognosis.Germline mutations in the BRCA1 DNA repair associated gene(BRCA1)and the BRCA2 DNA repair associated gene(BRCA2)account for 20%-25%of epithelial ovarian cancer(EOC).BRCA1 germline mutations are more common in Chinese EOC patients.Methods:This study reported a three-generation Han-Chinese family containing four EOC patients and a rectal adenocarcinoma patient.Whole-exome sequencing was performed on two EOC patients and an unaffected individual.Variant validation was also performed in all available members by Sanger sequencing.Results:A heterozygous splice site variant,c.4358-2A>G in the BRCA1 gene,was identified.Bioinformatic analysis showed that the variant may change the splicing machinery.Conclusion:The BRCA1 splice site variant,c.4358-2A>G was identified as the likely genetic cause for EOC,and may also be associated with the increased risk of rectal adenocarcinoma in the family.The findings were beneficial for genetic counseling,helpful for cancer prevention in other family members,and may facilitate therapy decision-making in the future to reduce cancer lethality.

更多
广告
作者 Peng-zhi HU [1] Xiang-yu CHEN [2] Wei XIONG [3] Zhi-jian YANG [2] Xiao-rong LI [4] Wen-zhi DENG [5] Li-na GONG [6] Hao DENG [7] La-mei YUAN [2] 学术成果认领
作者单位 Center for Experimental Medicine,the Third Xiangya Hospital,Central South University,Changsha 410013,China;Department of Radiology,the Third Xiangya Hospital,Central South University,Changsha 410013,China [1] Center for Experimental Medicine,the Third Xiangya Hospital,Central South University,Changsha 410013,China [2] Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education,Cancer Research Institute and School of Basic Medical Sciences,Central South University,Changsha 410078,China [3] Department of Gastrointestinal Surgery,the Third Xiangya Hospital,Central South University,Changsha 410013,China [4] Department of Pathology,the Third Xiangya Hospital,Central South University,Changsha 410013,China [5] Department of Neurology,the Third Xiangya Hospital,Central South University,Changsha 410013,China [6] Center for Experimental Medicine,the Third Xiangya Hospital,Central South University,Changsha 410013,China;Department of Neurology,the Third Xiangya Hospital,Central South University,Changsha 410013,China;Disease Genome Research Center,Central South University,Changsha 410013,China [7]
栏目名称 ORIGINAL ARTICLES
DOI 10.1007/s11596-022-2527-2
发布时间 2022-07-18
提交
  • 浏览7
  • 下载1
当代医学科学(英文)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷